Showing 15 posts of 17 posts found.


GSK’s tuberculosis vaccine shows efficacy over three years in HIV negative patients

October 29, 2019
Manufacturing and Production, Research and Development GSK, IAVI, Vaccine, pharma, tuberculosis

Promising results have been revealed from a GlaxoSmithKline study, conducted in partnership with non-profit scientific research organisation IAVI, investigating the …

FDA approve new drug for treatment-resistant TB

August 15, 2019
Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis

The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …


New diagnostic tool predicts tuberculosis infection with 73% accuracy

July 10, 2019
Research and Development diagnosis, pharma, tuberculosis

A new diagnostic technology has demonstrated the ability to identify human tuberculosis (TB) infection and those at highest risk of …


FDA advisory panel backs TB Alliance’s tuberculosis regimen

June 10, 2019
Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis

An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …

Global Fund seeks £11bn as progress slows in fight against malaria, TB and HIV

January 14, 2019
Sales and Marketing Africa, Global Fund, HIV, TB, infectious diseases, malaria, tuberculosis

The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …


J&J pledges to end global TB pandemic

September 25, 2018
Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis

Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …


Eisai forms partnership to find new tuberculosis treatment

April 13, 2018
Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …


Body’s natural defence mechanism against TB discovered

May 11, 2017
Research and Development Francis Crick Institute, TB, tuberculosis

Research conducted by the Francis Crick Institute has revealed how the body protects itself from Mycobacterium tuberculosis, the bacterium responsible …


Treatment combating multi-drug resistant TB posts positive results

March 27, 2017
Research and Development, Sales and Marketing Infectex, Sequella, tuberculosis

Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest …


Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town

March 8, 2016
Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee

The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …


Janssen in new collaboration to take on TB

December 3, 2015
Research and Development FIND, Janssen, antibiotic resistance, tuberculosis

Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …


Medicines Patent Pool to include hep C and TB drugs

November 9, 2015
Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis

The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …

Pfizer image

MSF hits out at ‘astronomical’ vaccine prices

January 20, 2015
Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis

Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …

Europe: TB treatment ‘far below’ target

March 19, 2014
Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis

European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …

FDA image

Janssen submits tuberculosis pill to FDA

July 4, 2012
Research and Development, Sales and Marketing Bedaquiline, FDA, J&J, JJ, Janssen, tuberculosis

Janssen has submitted its investigational tuberculosis pill bedaquiline for review by the FDA. The firm is seeking a licence for …

Latest content